ArticleArchives of microbiology2025
A novel soil Bacillus strain GB_SG_008: isolation, characterization, and anticancer potential of an intracellular protein fraction inducing apoptosis and modulating cancer marker proteins.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer continues to pose a significant global health challenge, with traditional therapies often limited by toxicity and resistance, underscoring the need for alternative strategies. Microorganisms and their bioactive products have emerged as valuable sources of novel anticancer agents. In this study, we isolated a wild-type bacterium from soil and performed a comprehensive taxonomic characterization. Phylogenetic analysis based on 16S rRNA gene sequencing, along with genome-based comparisons using average nucleotide identity (ANI), digital DNA-DNA hybridization (dDDH), average amino acid identity (AAI), and phylogenomic analysis, supported by detailed phenotypic profiling, confirmed the bacterium as a novel member of the genus Bacillus. Functional screening revealed that an intracellular protein fraction (~ 67 kDa) derived from this isolate exhibited potent anticancer activity against cervical and triple-negative breast cancer cells in vitro. Mechanistic studies demonstrated that the protein fraction suppresses cancer cell growth by inducing apoptosis, arresting cell cycle progression, and inhibiting colony formation and migration. Additionally, it modulated the expression of key cancer-associated proteins involved in survival, proliferation, and metastasis. Taken together, this work not only establishes the taxonomic and microbiological identity of a novel Bacillus isolate but also underscores its therapeutic promise as a source of anticancer proteins.
Indexed as
Identifiers
41108401What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.